Hexagon Capital Partners’s Steris STE Stock Holding History

Hexagon Capital Partners’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19	Closed	-$4.31K	–	1500
2025 Q1	$4.31K	Buy	19 +14	+280%	+$3.08K	﹤0.01%	1216
2024 Q4	$1.03K	Buy	+5	New	+$1.1K	﹤0.01%	1575
2024 Q3	–	Sell	-9	Closed	-$1.98K	–	1638
2024 Q2	$1.98K	Buy	+9	New	+$1.96K	﹤0.01%	1178

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Hexagon Capital Partners's STE Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Steris (STE) in Q2 2025, closing a stake of 19 shares — an estimated $4.31K sold.

Hexagon Capital Partners first reported a position in STE in Q2 2024 and held it in 3 quarters. The position peaked at $4.31K in Q1 2025. 834 funds tracked by Wall St. Rank hold STE as of Q2 2025.

Hexagon Capital Partners reported no remaining Steris position as of Q2 2025 after selling out during the quarter.
Hexagon Capital Partners sold 19 Steris shares in Q2 2025, an estimated $4.31K.
Hexagon Capital Partners first reported a position in Steris in Q2 2024 and held it in 3 quarters.
Hexagon Capital Partners's Steris position peaked at $4.31K in Q1 2025.
834 funds tracked by Wall St. Rank held Steris as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.